13D Filing: Cetus Capital Ii, Llc and Pernix Therapeutics Holdings, Inc. (PTX)

Page 9 of 10

Page 9 of 10 – SEC Filing

 

SIGNATURES

 

After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

 

 

Dated: April 15, 2016

Cetus Capital III, L.P.

 

 

 

By: Littlejohn Associates V, L.L.C., its general partner

 

 

 

 

 

Name:

/s/ Robert E. Davis

 

By:

Robert E. Davis, authorized signatory

 

 

Dated: April 15, 2016

Cetus Capital II, LLC

 

 

 

By: Littlejohn Fund IV, L.P., manager

 

By: Littlejohn Associates IV, L.L.C., its general partner

 

 

 

 

 

Name:

/s/ Robert E. Davis

 

By:

Robert E. Davis, authorized signatory

 

 

Dated: April 15, 2016

Littlejohn Opportunities Master Fund LP

 

 

 

By: Littlejohn Opportunities GP LLC, its general partner

 

 

 

 

 

Name:

/s/ Robert E. Davis

 

By:

Robert E. Davis, authorized signatory

 

 

 

 

Dated: April 15, 2016

SG Distressed Fund, LP

 

 

 

By: Littlejohn Opportunities GP LLC, its general partner

 

 

 

 

 

Name:

/s/ Robert E. Davis

 

By:

Robert E. Davis, authorized signatory

 

8


Follow Pernix Therapeutics Holdings Inc. (NASDAQ:PTX)

Page 9 of 10